Am J Perinatol 2010; 27(9): 705-710
DOI: 10.1055/s-0030-1253102
© Thieme Medical Publishers

Barriers to Follow-up for Women with a History of Gestational Diabetes

Alison Stuebe1 , Jeffrey Ecker2 , David W. Bates3 , Chloe Zera4 , Rhonda Bentley-Lewis5 , Ellen Seely5
  • 1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina
  • 2Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts
  • 3Division of General Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health, Boston, Massachusetts
  • 4Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, Massachusetts
  • 5Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts
Further Information

Publication History

Publication Date:
12 April 2010 (online)

ABSTRACT

Women with gestational diabetes (GDM) are at increased risk for type 2 diabetes (T2DM), but many do not receive recommended follow-up. We sought to identify barriers to follow-up screening. We surveyed primary care providers (PCPs) and obstetric and gynecology care providers (OBCPs) in a large health system. We also assessed documentation of GDM history in the health care system's electronic medical record. Four hundred seventy-eight clinicians were surveyed, among whom 207 responded. Most participants (81.1%) gave an accurate estimate of risk of progression to T2DM. PCPs were less likely than OBCPs to ask patients about history of GDM (odds ratio [OR] 0.43, 95% confidence interval [CI] 0.20 to 0.90), but they were far more likely to indicate that they order glucose screening for women with a known history (OR 4.31, 95% CI 2.01 to 9.26). Providers identified poor communication between OBCPs and PCPs as a major barrier to screening. Fewer than half (45.8%) of 450 women with GDM by glucose tolerance test criteria had that history documented on their electronic problem list. Clinicians are aware that women with GDM are at high risk of developing type 2 diabetes, but they do not routinely assess and screen patients, and communication between OBCPs and PCPs can be improved.

REFERENCES

  • 1 Cheung N W, Byth K. Population health significance of gestational diabetes.  Diabetes Care. 2003;  26 2005-2009
  • 2 American Diabetes Association . Gestational diabetes mellitus.  Diabetes Care. 2004;  27(Suppl 1) S88-S90
  • 3 Committee on Obstetric Practice . ACOG Committee Opinion No. 435: postpartum screening for abnormal glucose tolerance in women who had gestational diabetes mellitus.  Obstet Gynecol. 2009;  113 1419-1421
  • 4 Cheung N W, Byth K. Population health significance of gestational diabetes.  Diabetes Care. 2006;  26(7) 2005-2009
  • 5 Knowler W C, Barrett-Connor E, Fowler S E Diabetes Prevention Program Research Group et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.  N Engl J Med. 2002;  346 393-403
  • 6 Tuomilehto J, Lindström J, Eriksson J G Finnish Diabetes Prevention Study Group et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.  N Engl J Med. 2001;  344 1343-1350
  • 7 Pan X R, Li G W, Hu Y H et al.. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.  Diabetes Care. 1997;  20 537-544
  • 8 Chiasson J-L, Josse R G, Gomis R, Hanefeld M, Karasik A, Laakso M. STOP-NIDDM Trail Research Group . Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.  Lancet. 2002;  359 2072-2077
  • 9 Kim C, Tabaei B P, Burke R et al.. Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus.  Am J Public Health. 2006;  96 1643-1648
  • 10 Smirnakis K V, Chasan-Taber L, Wolf M, Markenson G, Ecker J L, Thadhani R. Postpartum diabetes screening in women with a history of gestational diabetes.  Obstet Gynecol. 2005;  106 1297-1303
  • 11 Sequist T D, Gandhi T K, Karson A S et al.. A randomized trial of electronic clinical reminders to improve quality of care for diabetes and coronary artery disease.  J Am Med Inform Assoc. 2005;  12 431-437
  • 12 Cabana M D, Rand C S, Powe N R et al.. Why don't physicians follow clinical practice guidelines? A framework for improvement.  JAMA. 1999;  282 1458-1465
  • 13 Carpenter M W, Coustan D R. Criteria for screening tests for gestational diabetes.  Am J Obstet Gynecol. 1982;  144 768-773
  • 14 Kim C, Newton K M, Knopp R H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review.  Diabetes Care. 2002;  25 1862-1868
  • 15 Gabbe S, Hill L, Schmidt L, Schulkin J. Management of diabetes by obstetrician-gynecologists.  Obstet Gynecol. 1998;  91(5 Pt 1) 643-647
  • 16 Power M L, Cogswell M E, Schulkin J. Obesity prevention and treatment practices of U.S. obstetrician-gynecologists.  Obstet Gynecol. 2006;  108 961-968
  • 17 Ramsey P S, Nuthalapaty F S, Lu G, Ramin S, Nuthalapaty E S, Ramin K D. Contemporary management of preterm premature rupture of membranes (PPROM): a survey of maternal-fetal medicine providers.  Am J Obstet Gynecol. 2004;  191 1497-1502
  • 18 Gabbe S G, Gregory R P, Power M L, Williams S B, Schulkin J. Management of diabetes mellitus by obstetrician-gynecologists.  Obstet Gynecol. 2004;  103 1229-1234
  • 19 DesRoches C M, Campbell E G, Rao S R et al.. Electronic health records in ambulatory care—a national survey of physicians.  N Engl J Med. 2008;  359 50-60
  • 20 Simon S R, Soran C S, Kaushal R et al.. Physicians' use of key functions in electronic health records from 2005 to 2007: a statewide survey.  J Am Med Inform Assoc. 2009;  16 465-470
  • 21 Almario C V, Ecker T, Moroz L A et al.. Obstetricians seldom provide postpartum diabetes screening for women with gestational diabetes.  Am J Obstet Gynecol. 2008;  198 528.e1-5
  • 22 Dietz P M, Vesco K K, Callaghan W M et al.. Postpartum screening for diabetes after a gestational diabetes mellitus-affected pregnancy.  Obstet Gynecol. 2008;  112 868-874
  • 23 Hunt K J, Conway D L. Who returns for postpartum glucose screening following gestational diabetes mellitus?.  Am J Obstet Gynecol. 2008;  198 404.e1-6
  • 24 Kaufmann R C, Smith T, Bochantin T, Khardori R, Evans M S, Steahly L. Failure to obtain follow-up testing for gestational diabetic patients in a rural population.  Obstet Gynecol. 1999;  93(5 Pt 1) 734-737
  • 25 Bentley-Lewis R, Levkoff S, Stuebe A, Seely E W. Gestational diabetes mellitus: postpartum opportunities for the diagnosis and prevention of type 2 diabetes mellitus.  Nat Clin Pract Endocrinol Metab. 2008;  4 552-558
  • 26 Gandhi T K, Kachalia A, Thomas E J et al.. Missed and delayed diagnoses in the ambulatory setting: a study of closed malpractice claims.  Ann Intern Med. 2006;  145 488-496

Alison StuebeM.D. M.Sc. 

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina School of Medicine

3010 Old Clinic Building, CB 7516, Chapel Hill, NC 27599

Email: astuebe@med.unc.edu

    >